Abstract:
본 발명은 골든밸리(Golden Valley) 감자 유래의 Ry(Resistance Potato virus Y) 유전자를 포함하는 재조합 식물 발현 벡터로 형질전환된, PVY(Potato virus Y)에 내성이 있는 형질전환 감자 식물체 및 상기 재조합 식물 발현 벡터로 감자 식물체를 형질전환시키는 단계를 포함하는 감자 식물체의 PVY(Potato virus Y)에 대한 내성을 증가시키는 방법에 관한 것이다. 골든밸리, 감자, Ry 유전자, PVY, 형질전환
Abstract:
본발명은주석산을유효성분으로포함하는고혈압예방또는치료용약학적조성물및 고혈압예방또는개선용건강기능식품관한것으로, 구체적으로본 발명의유효성분인주석산은안지오텐신 I 전환효소(angiotensin I converting enzyme; ACE)의활성을저해하여혈관수축을억제하며, 세포독성이거의나타나지않으므로고혈압의예방또는치료용약학조성물및 고혈압예방또는개선용건강기능식품으로서유용하게사용될수 있다.
Abstract:
PURPOSE: A pine needle fermentation liquid for improving blood circulation is provided to reduce blood cholesterol content, neutral lipid, and thrombus and treat cardiovascular diseases such as hypertension, hyperlipidemia and arteriosclerosis. CONSTITUTION: A pine needle fermentation liquid for reducing cholesterol with increased phenol compound and thrombus is prepared by storing and fermenting pine needle extract for one to ten years. The phenol compound is 1,8-cineole/eucalyptol, 2-methyl-1-butanol, 3-methyl-1-butanol, 5-isopyrenyl-2-2-methyl-2vinyltetrahydrofuran, bicyclo[2,2,1]heptan-2-ol, camphor, herboxide second isomer, hexanoic acid, ethyl ester, or isocineole. A pharmaceutical composition for preventing or treating cardiovascular diseases contains the pine needle fermentation liquid as an active ingredient.